Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future
Roberto Diletti1, Tuncay Yetgin, Olivier C Manintveld
1Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Summary
This review explores innovations in reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Future perspectives include advanced stents, stem cell therapy, and optimized vascular access for improved patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Regenerative Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) remains a critical condition requiring timely reperfusion.
- Current treatment strategies are evolving with technological advancements and novel therapeutic approaches.
Purpose of the Study:
- To review recent innovations in reperfusion treatment for STEMI.
- To discuss future perspectives and potential advancements in STEMI management.
Main Methods:
- Literature review of recent innovations in STEMI reperfusion therapy.
- Analysis of emerging technologies and treatment strategies.
Main Results:
- Shift towards radial vascular access over femoral access.
- Introduction of bioresorbable coronary scaffolds and STEMI-specific stents.
- Exploration of cardioprotective strategies and autologous bone marrow stem cell transplantation.
Conclusions:
- The field of STEMI reperfusion is rapidly advancing.
- Future treatments may integrate novel devices and regenerative therapies for enhanced patient recovery.
More Related Videos
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
1.9K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
01:28Acute Coronary Syndrome IV: Interprofessional Care
514
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
811
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
811
01:30Acute Coronary Syndrome III: Diagnostic Studies
492
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
492
01:27Coronary Artery Disease V: Interprofessional Care
442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
01:28Cardiac Catheterization I: Pre-Procedure Overview
3.3K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.3K